登录 注册 会员服务 联系我们

Expensive drugs for rare disorders: to treat or not to treat? The case of enzyme replacement therapy for mucopolysaccharidosis VI

  • Published:2009-04-07 Issue:5 Volume:25 Page:1285-1293
  • ISSN:0300-7995
  • Container-title:Current Medical Research and Opinion
  • language:en
  • Short-container-title:Current Medical Research and Opinion

Author:

Schlander M.123,Beck M.24

Affiliation:

1. Institute for Innovation & Valuation in Health Care (InnoVal HC), Wiesbaden, Germany

2. University of Heidelberg, Mannheim Institute for Public Health, Social and Preventive Medicine, Mannheim, Germany

3. University of Applied Economic Sciences Ludwigshafen, Ludwigshafen, Germany

4. University of Mainz, Children's Hospital, Mainz, Germany

Publisher

Informa Healthcare

Subject

General Medicine

Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health service utilization, economic burden and quality of life of patients with mucopolysaccharidosis in China;Orphanet Journal of Rare Diseases;2024-09-06

2. Consensus-based expert recommendations on the management of MPS IVa and VI in Saudi Arabia;Orphanet Journal of Rare Diseases;2024-07-17

3. 5. Genetic Research With Minority Populations;Race and Research: Perspectives on Minority Participation in Health Studies, 2nd ed.;2024-01

4. Ethical considerations in precision medicine;The New Era of Precision Medicine;2024

5. Literature Review on Health Emigration in Rare Diseases—A Machine Learning Perspective;International Journal of Environmental Research and Public Health;2023-01-30
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3